Table 2.
Asymptomatic patients.
Patient | Age (years) | Setting | Underlying disease | Risk factors | Reason for imaging | Anticoagulation therapy | Treatment duration | Radiological follow-up (6 months) |
---|---|---|---|---|---|---|---|---|
#1 | 14 | Inpatient (20 days) | Metastatic osteosarcoma | Malignancy | Tumor staging | Enoxaparin, 1 mg/kg/dose q12h | 10 months | Chronic PE |
#2 | 2 | Inpatient (22 days) | T-cell acute lymphoblastic leukemia | Malignancy + Drug¹ + Infection + CVC² | Fever of unknown origin | Enoxaparin, 1 mg/kg/dose q12h | 6 months | Chronic PE |
#3 | 15 | Outpatient | Metastatic Ewing sarcoma | Malignancy | Tumor staging | Enoxaparin, 1.2 mg/kg/dose q12h | 3 months | Complete resolution |
#4 | 2 | Inpatient (33 days) | Double outlet right ventricle + Interatrial and interventricular communication | Congenital heart disease + Recent surgery + CVC | Postoperative imaging control | Enoxaparin, 1.4 mg/kg/dose q12h | Not reported | Complete resolution |
#5 | 3 | Inpatient (8 days) | Right adrenocortical carcinoma | Malignancy + Recent surgery | Postoperative imaging control | Enoxaparin, 1 mg/kg/dose q12h | 3 months | Complete resolution |
Asparaginase;
Central venous catheter.